Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
19,135
+2,193
+13% +$14.5K ﹤0.01% 1708
2026
Q1
$87.8K Buy
16,942
+3,810
+29% +$23.8K ﹤0.01% 1584
2025
Q4
$96K Buy
13,132
+242
+2% +$2.34K ﹤0.01% 1470
2025
Q3
$129K Sell
12,890
-1,769
-12% -$19.6K ﹤0.01% 1418
2025
Q2
$133K Buy
14,659
+566
+4% +$3.69K ﹤0.01% 1383
2025
Q1
$90.5K Buy
14,093
+596
+4% +$5.3K ﹤0.01% 1355
2024
Q4
$128K Buy
13,497
+1,986
+17% +$17.4K ﹤0.01% 1340
2024
Q3
$94.1K Buy
+11,511
New +$120K ﹤0.01% 1321

Other funds holding ENVX

Xponance's ENVX Position: Q2 2026 in Review

Xponance increased its Enovix (ENVX) stake by 13% in Q2 2026, buying an estimated $14.5K and bringing the position to 19,135 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Xponance first reported a position in ENVX in Q3 2024 and has held it in 8 quarters since. The position peaked at $133K in Q2 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Xponance held 19,135 shares of Enovix worth $116K as of Q2 2026.
  • Xponance bought 2,193 Enovix shares in Q2 2026, an estimated $14.5K.
  • Enovix made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1708 holding.
  • Xponance first reported a position in Enovix in Q3 2024 and has held it in 8 quarters since.
  • Xponance's Enovix position peaked at $133K in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.